ENDRA Life Sciences Inc. Warrants
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$11,352,321 over the previous period. Total operating expenses were $11,498,305.

Profit Margin

ENDRA Life Sciences Inc. Warrants (NASDAQ:NDRAW): Profit margin
2014 559.35K -2.18M -389.89%
2015 1.41M -2.27M -161.64%
2016 515.58K -2.77M -538.3%
2017 351.62K -5.37M -1529.19%
2018 6.17K -9.79M -158669.6%
2019 0 -17.52M
2020 0 -11.72M
2021 0 -11.35M

NDRAW Income Statement (2014 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0006.17K351.62K515.58K1.41M559.35K
Cost of revenue
0000172.78K235.87K666.23K259.14K
Gross profit
0006.17K178.84K279.70K743.83K300.21K
Operating exp.
Research and development
5.48M5.91M6.57M4.72M1.93M495.37K1.03M873.16K
Selling and marketing
1.07M581.89K412.43K262.64K122.60K34.13K50.63K56.29K
Total operating expenses
11.49M11.50M10.84M9.02M4.80M2.07M2.31M1.82M
Operating income
-11.23M-11.50M-10.84M-9.01M-4.62M-1.79M-1.56M-1.52M
Other income (expenses), net
0-223.58K-2.46M-777.25K-750.90K-983.61K-710.63K-654.69K
Income before tax
-11.23M-11.72M-13.30M-9.79M-5.37M-2.77M-2.27M-2.18M
Income tax expense
121.07K8.84K-106.90K-777.25K-750.90K-983.61K-710.63K-654.69K
Net income
-11.35M-11.72M-17.52M-9.79M-5.37M-2.77M-2.27M-2.18M
Earnings per share
Basic EPS
-0.82-0.85-2.34-2.17-1.95-1.01-0.83-0.79
Diluted EPS
-0.82-0.85-2.34-2.17-1.95-1.01-0.83-0.79
Data sourceData sourceData sourceData sourceData source